ENALARE THERAPEUTICS
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory and critical care conditions including respiratory depression caused by drug overdose, post-surgery, and pathogens.
ENALARE THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
Naples, Florida, United States
Country:
United States
Website Url:
http://www.enalare.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
23.53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Alterome Therapeutics
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Cyclerion Therapeutics
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Employees Featured
Founder
Investors List
Eagle Pharmaceuticals
Eagle Pharmaceuticals investment in Corporate Round - Enalare Therapeutics
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Enalare Therapeutics
Official Site Inspections
http://www.enalare.com
- Host name: ec2-3-222-209-23.compute-1.amazonaws.com
- IP address: 3.222.209.23
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Enalare Therapeutics"
Enalare Therapeutics - Crunchbase Company Profile & Funding
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory and critical …See details»
Enalare Therapeutics Inc.
Enalare Therapeutics Inc. Developing and commercializing novel therapies for life-threatening acute respiratory and critical care conditions April 2021 ... Organization (CRO) Corporate …See details»
Enalare Company Profile 2024: Valuation, Funding & Investors
Enalare was founded in 2018. Where is Enalare headquartered? Enalare is headquartered in Princeton, NJ. What is the size of Enalare? Enalare has 10 total employees. What industry is …See details»
Our Focus - Enalare Therapeutics
1 US HHS CDC, 12-month ending Jan. 2021, data available as of Sept. 2021. 2 NIH National Institute on Drug Abuse. 3 Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on …See details»
Enalare Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Enalare Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 19 news, and 9 literature, Technology Platform:Small molecule drug, Drug:ENA …See details»
Enalare Therapeutics - Funding, Financials, Valuation & Investors
Enalare Therapeutics is a clinical stage biopharmaceutical company dedicated to developing novel therapies. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»
Enalare Therapeutics - Contacts, Employees, Board Members, …
Enalare Therapeutics has 2 current employee profiles, including Executive Chairman, President, and CEO Herm Cukier. Herm Cukier Executive Chairman, President, and CEO Joseph …See details»
Enalare - Company Profile - Tracxn
Nov 27, 2024 Enalare. has raised a total funding of $35M over 2 rounds. Its first funding round was on Feb 02, 2021. What are the most recent funding rounds of Enalare? Its latest funding …See details»
Enalare Therapeutics Inc.
Oct 15, 2021 Enalare Therapeutics Inc. Developing Novel Therapies for Life-threatening Critical Care Conditions October 2021 Contact: Daniel Motto, Chief Operating Officer …See details»
ENALARE THERAPEUTICS LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ENALARE THERAPEUTICS LLC of Naples, FL. Get the latest business insights from Dun & Bradstreet.See details»
Enalare Therapeutics - Overview, News & Similar companies
Mar 7, 2023 Who is Enalare Therapeutics. Enalare Therapeutics, founded in 2019 and headquartered in Princeton, NJ, is a clinical-stage biopharmaceutical company dedicated to …See details»
Enalare Therapeutics - Overview, News & Similar companies
Enalare Therapeutics Inc is a company that operates in the Pharmaceuticals industry. It employs 5to9 people and has 500Kto1M of revenue. The compan y is headquartered in Naples, …See details»
Enalare Therapeutics Appoints Daniel Motto as Chief Business …
NAPLES, Fla., November 9, 2020 (Newswire.com) - Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing and commercializing novel therapies for …See details»
Enalare Receives FDA Clearance to Initiate the First Phase 1 Clinical ...
Sep 24, 2024 PRINCETON, NJ / ACCESSWIRE / September 24, 2024 /Enalare Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to developing novel compounds …See details»
Enalare Overview Oct 30 2020-2
Oct 30, 2020 ENALARE—a therapeutic breathing enhancerInitial Target Markets 5 Respiratory Depression is a condition characterized by slow and ineffective breathing resulting in: • low …See details»
Press Releases - Enalare Therapeutics
Mar 8, 2023 Furthermore, Enalare was also named along with its research partner organization, NEMA Research, Inc., as one of only four nominees for Best Clinical Partnership of the year. …See details»
Enalare Therapeutics, Inc. (Enalare Therapeutics, Inc.) - 药物管线_ …
了解Enalare Therapeutics, Inc. (Enalare Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的2项临床试验, 20篇新闻和9篇文献，技术平台:小分子化药，药物:ENA-001，ENA …See details»
Contact Us - Enalare Therapeutics
Enalare Therapeutics Want to learn more? Contact us directly via email at [email protected].. © 2021 Enalare Therapeutics Inc.See details»